Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -145,231 | -163,619 | -128,724 | -57,796 | -19,931 |
| Depreciation Amortization | -7,916 | -8,145 | -172 | 2,583 | 2,078 |
| Accounts receivable | -33,914 | -5,432 | -543 | -876 | N/A |
| Other Working Capital | -66,325 | -324 | 6,839 | -7,489 | -7,829 |
| Other Operating Activity | 118,049 | 56,720 | 49,007 | 17,658 | 11,525 |
| Operating Cash Flow | $-135,337 | $-120,800 | $-73,593 | $-45,920 | $-14,157 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -358 | -807 | -358 | -1,351 | -569 |
| Purchase Of Investment | -380,376 | -303,919 | -802,503 | -118,662 | -194,927 |
| Sale Of Investment | 476,132 | 449,480 | 408,016 | 158,848 | 289,971 |
| Investing Cash Flow | $95,398 | $144,754 | $-394,845 | $38,835 | $94,475 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 100,842 | 2,472 | 11,827 | 2,553 | 496 |
| Common Stock Repurchased | -456 | -50,000 | 0 | N/A | N/A |
| Other Financing Activity | 26,668 | -11,769 | 32,190 | 249,745 | -1,375 |
| Financing Cash Flow | $127,054 | $-59,297 | $44,017 | $252,298 | $-879 |
| Beginning Cash Position | 35,965 | 71,308 | 495,729 | 250,516 | 171,077 |
| End Cash Position | 123,080 | 35,965 | 71,308 | 495,729 | 250,516 |
| Net Cash Flow | $87,115 | $-35,343 | $-424,421 | $245,213 | $79,439 |
| Free Cash Flow | |||||
| Operating Cash Flow | -135,337 | -120,800 | -73,593 | -45,920 | -14,157 |
| Capital Expenditure | -358 | -807 | -358 | -1,366 | -569 |
| Free Cash Flow | -135,695 | -121,607 | -73,951 | -47,286 | -14,726 |